CHS — Comprehensive Healthcare Systems Income Statement
0.000.00%
Last trade - 00:00- CA$8.62m
- CA$12.00m
- $3.77m
- 15
- 53
- 53
- 34
Annual income statement for Comprehensive Healthcare Systems, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final |
| Revenue | ||||
| Total Revenue | 4.5 | 4.3 | 3.84 | 3.77 |
| Cost of Revenue | ||||
| Gross Profit | 1.37 | 1.4 | 1.15 | 2.06 |
| Selling / General / Administrative Expenses | ||||
| Research And Development | ||||
| Depreciation and Amortization | ||||
| Unusual Expense / Income | ||||
| Total Operating Expenses | 8.4 | 9.1 | 7.17 | 4.18 |
| Operating Profit | -3.91 | -4.79 | -3.33 | -0.412 |
| Total Net Non Operating Interest Income / Expense | ||||
| Other Net Non Operating Costs | ||||
| Net Income Before Taxes | -4.93 | -5.11 | -3.58 | -0.608 |
| Net Income After Taxes | -4.93 | -5.11 | -3.58 | -0.608 |
| Net Income Before Extraordinary Items | ||||
| Net Income | -4.93 | -5.11 | -3.58 | -0.608 |
| Income Available to Common Shareholders Excluding Extraordinary Items | ||||
| Income Available to Common Shareholders Including Extraordinary Items | ||||
| Diluted Net Income | -4.93 | -5.11 | -3.58 | -0.608 |
| Diluted Weighted Average Shares | ||||
| Basic EPS Including Extraordinary Items | ||||
| Diluted EPS Including Extraordinary Items | ||||
| Diluted EPS Excluding Extraordinary Items | ||||
| Normalised Income Before Taxes | ||||
| Normalised Income After Taxes | ||||
| Normalised Income Available to Common Shareholders | ||||
| Diluted Normalised EPS | -2.32 | -1.49 | -0.578 | -0.19 |